Angiotensin II receptor antagonist

Known as: Angiotensin II Receptor Blockers, Angiotensin Receptor Blockers, ARB 
A class of agents that act by selectively inhibiting angiotensin II receptor activation in the renin-angiotensin-aldosterone system. Angiotensin II… (More)
National Institutes of Health

Related topics

Related topics

5 relations
Angiotensin 2 Receptor Antagonists [MoA]Angiotensin 2 Receptor Blocker [EPC]Pharmacologic Substance

Broader (2)

Angiotensin Receptor AntagonistsReceptor, Angiotensin II

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
Angiotensin II blockade and aortic-root dilation in Marfan's syndrome.
BACKGROUND Progressive enlargement of the aortic root, leading to dissection, is the main cause of premature death in patients… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Review
2005
Review
2005
Angiotensin II receptor antagonist treatment during pregnancy.
Angiotensin II (A-II) is the main effector of the renin-angiotensin system. A-II functions by binding its type 1 (AT1) receptors… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists.
The number of circulating endothelial progenitor cells (EPCs) correlates with endothelial dysfunction and cardiovascular risk in… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity.
The metabolic syndrome is a common precursor of cardiovascular disease and type 2 diabetes that is characterized by the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis.
The therapeutic efficacy of angiotensin II receptor antagonist, losartan, was studied in patients with nonalcoholic… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Four-Year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other artihypertensive drug classes.
BACKGROUND It has been reported that a statistically greater percentage of patients initially treated with losartan, an… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats.
Effects of oral administration of the angiotensin II receptor antagonist (selective AT(1)-subtype) irbesartan on glucose… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2000
Review
2000
Angiotensin II receptor antagonists
Blockade of the renin-angiotensin system began as a way of studying the pathogenesis of cardiovascular disease with specific… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction.
Unilateral ureteral obstruction (UUO) results in tubulointerstitial fibrosis of the obstructed kidney (OBK). In this study we… (More)
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans.
The pharmacokinetics of the angiotensin II receptor antagonist losartan potassium and its active carboxylic acid metabolite… (More)
Is this relevant?